Literature DB >> 31002918

Role of AMPK and its molecular intermediates in subjugating cancer survival mechanism.

Anand Thirupathi1, Yan-Zhong Chang2.   

Abstract

The gradual energy dissipation of all organisms allows adapting to energy demands. Pathological situations of uncured diseases such as cancer, diabetes, and other obesity-related diseases are caused by an abrupt energy imbalance. As an energy sensor, AMP-activated kinase (AMPK) can regulate the cellular energy status. In case of increased energy demands or insufficient nutrient supply, cells digest their own interior, which is called autophagy. AMPK-mediated autophagy regulates various metabolic and physiological processes and is dysregulated in different chronic conditions. Because of AMPK's critical role in physiology and pathology, it is an emerging target for both prevention and treatment of these uncured diseases. This review discusses the multifaceted role of AMPK on cancer cell survival and inhibition mechanism. First, we discuss the dual role of AMPK on cancer progression and suppression, and we discuss how different AMPK subunit combinations influence the tumor progression and suppression. Next, we discuss what could be the centering point of AMPK that supports promotion or inhibition of the cancer cell growth. Furthermore, we review the role of connecting mechanism of AMPK-mediated molecular intermediates on cancer cell survival and inhibition pathways. Finally, we discuss how AMPK can affect DNA damage and repairing mechanisms, and immune response of host cell and cancer cells.
Copyright © 2019 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  AMPK; Autophagy; Cancer; LKB1; Lipogenesis; Neoantigen

Mesh:

Substances:

Year:  2019        PMID: 31002918     DOI: 10.1016/j.lfs.2019.04.039

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  12 in total

1.  A-769662 stimulates the differentiation of bone marrow-derived mesenchymal stem cells into osteoblasts via AMP-activated protein kinase-dependent mechanism.

Authors:  Basem M Abdallah; Abdullah M Alzahrani
Journal:  J Appl Biomed       Date:  2021-07-01       Impact factor: 1.797

2.  Palbociclib regulates intracellular lipids in mammary tumor cells by secreting lipoprotein lipase.

Authors:  Tomoyasu Fujii; Jun Kamishikiryo; Tetsuo Morita
Journal:  Pharmacol Rep       Date:  2022-04-03       Impact factor: 3.024

3.  Snail acetylation by autophagy-derived acetyl-coenzyme A promotes invasion and metastasis of KRAS-LKB1 co-mutated lung cancer cells.

Authors:  Jang Hee Han; Yong Keon Kim; Hakhyun Kim; Jooyoung Lee; Myung Joon Oh; Sang Bum Kim; Minjee Kim; Kook Hwan Kim; Hyun Ju Yoon; Myung-Shik Lee; John D Minna; Michael A White; Hyun Seok Kim
Journal:  Cancer Commun (Lond)       Date:  2022-07-15

4.  PPM-18, an Analog of Vitamin K, Induces Autophagy and Apoptosis in Bladder Cancer Cells Through ROS and AMPK Signaling Pathways.

Authors:  Huiai Lu; Chunlei Mei; Luhao Yang; Junyan Zheng; Junwei Tong; Fengsen Duan; Huageng Liang; Ling Hong
Journal:  Front Pharmacol       Date:  2021-07-09       Impact factor: 5.810

Review 5.  Cancer Etiology: A Metabolic Disease Originating from Life's Major Evolutionary Transition?

Authors:  B Poljsak; V Kovac; R Dahmane; T Levec; A Starc
Journal:  Oxid Med Cell Longev       Date:  2019-10-08       Impact factor: 6.543

6.  Resveratrol As A Natural Regulator Of Autophagy For Prevention And Treatment Of Cancer.

Authors:  Yuanyuan Tian; Wenjing Song; Dan Li; Lu Cai; Yuguang Zhao
Journal:  Onco Targets Ther       Date:  2019-10-17       Impact factor: 4.147

7.  CARM1 promotes gastric cancer progression by regulating TFE3 mediated autophagy enhancement through the cytoplasmic AMPK-mTOR and nuclear AMPK-CARM1-TFE3 signaling pathways.

Authors:  Suzhen Yang; Jing Zhang; Di Chen; Jiayi Cao; Ying Zheng; Yuying Han; Yirong Jin; Shuhui Wang; Ting Wang; Lin Ma; Tingting Luo; Yan Wang; Wen Qin; Lei Dong
Journal:  Cancer Cell Int       Date:  2022-03-04       Impact factor: 5.722

Review 8.  Purine-Metabolising Enzymes and Apoptosis in Cancer.

Authors:  Marcella Camici; Mercedes Garcia-Gil; Rossana Pesi; Simone Allegrini; Maria Grazia Tozzi
Journal:  Cancers (Basel)       Date:  2019-09-12       Impact factor: 6.639

9.  NOD2 inhibits tumorigenesis and increases chemosensitivity of hepatocellular carcinoma by targeting AMPK pathway.

Authors:  Xiaomin Ma; Yumin Qiu; Yanlin Sun; Lihui Zhu; Yunxue Zhao; Tao Li; Yueke Lin; Dapeng Ma; Zhenzhi Qin; Caiyu Sun; Lihui Han
Journal:  Cell Death Dis       Date:  2020-03-06       Impact factor: 8.469

10.  Metformin as an Adjuvant to Photodynamic Therapy in Resistant Basal Cell Carcinoma Cells.

Authors:  Marta Mascaraque; Pablo Delgado-Wicke; Cristina Nuevo-Tapioles; Tamara Gracia-Cazaña; Edgar Abarca-Lachen; Salvador González; José M Cuezva; Yolanda Gilaberte; Ángeles Juarranz
Journal:  Cancers (Basel)       Date:  2020-03-13       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.